Chronic Kidney Disease News

Long-term patiromer use may be associated with a lower risk of all-cause mortality in adults with chronic kidney disease and hyperkalemia, according to results of published study.

Researchers identified multiple proteins linked to a higher risk of major cardiovascular events in a study that analyzed blood tests from older adults with kidney disease.

Fresenius Medical Care has received FDA 510(k) clearance for its 5008X Hemodialysis System, allowing for the start of U.S.-based clinical trials, according to a press release.

Advanced image-guided percutaneous and advanced laparoscopic techniques are both acceptable options to place peritoneal dialysis catheters, published data show.

Adults with type 2 diabetes and chronic kidney disease derive similar cardiovascular and kidney benefits from finerenone, regardless of their level of insulin resistance, according to findings published in Diabetes Care.

Older adults with low eGFR based on creatinine and cystatin C levels may be at higher risk for adverse events compared with those who have low eGFR based on creatinine level, data show.

Kidney dysfunction may play a key role in hospital death and the outcome of thrombolysis in patients who have experienced a stroke, according to a recently published study.

An experimental drug that inhibits aldosterone production reduced albuminuria in patients with chronic kidney disease, according to phase 2 study results published in The Lancet.

Adults who achieve type 2 diabetes remission are less likely to develop chronic kidney disease and cardiovascular disease, according to study findings published in Diabetologia.

Commercially available alkaline water has minimal alkali content and offers no benefits compared with tap water and other methods for adults with uric acid and cystine urolithiasis, data show.